CSGP vs ZVRA · P/E 484, rev $1.82B vs P/E 6.3, rev $75.9M
CoStar Group Inc (CSGP) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2026-06-30 was $1.82B. Net income was $58.0M. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the CSGP and ZVRA stock pages for the full models.
Not investment advice.